Total Clarity Wealth Management, Inc. Sarepta Therapeutics, Inc. Transaction History

Total Clarity Wealth Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$63.15 - $90.42 $2,652 - $3,797	-42 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$65.97 - $92.48 $2,770 - $3,884	42 New	42 $4,000
Q2 2021 Jul 26, 2021	SELL	$69.38 - $86.75 $2,913 - $3,643	-42 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$72.25 - $168.95 $3,034 - $7,095	42 New	42 $3,000
Q1 2020 Apr 24, 2020	SELL	$82.38 - $131.64 $3,459 - $5,528	-42 Closed	0 $0
Q4 2019 Feb 27, 2020	BUY	$76.53 - $135.58 $3,214 - $5,694	42 New	42 $5,000

529

84.1M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11.1B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.